Cardlytics, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $233.3M | $278.3M | $309.2M | $298.5M | $267.1M |
| Research and development | $39.8M | $49.6M | $51.4M | $54.4M | $38.1M |
| Operating income | -$101.8M | -$195.5M | -$135.7M | -$457.8M | -$122.6M |
| Interest expense | $10.6M | $8.9M | $6.2M | $4.0M | — |
| Pretax income | -$103.5M | -$189.3M | -$134.7M | -$466.7M | -$136.4M |
| Income tax expense | $0 | $0 | $0 | -$1.4M | -$7.9M |
| Net income | -$103.5M | -$189.3M | -$134.7M | -$465.3M | -$128.6M |
| Balance Sheet | |||||
| Cash and equivalents | $48.7M | $65.6M | $91.8M | $121.9M | $233.5M |
| Current assets | $137.3M | $178.0M | $223.9M | $250.0M | $358.7M |
| Total assets | $285.6M | $392.7M | $574.1M | $691.2M | $1.3B |
| Current liabilities | $78.4M | $149.0M | $171.1M | $248.9M | $327.4M |
| Total liabilities | $292.1M | $322.7M | $439.3M | $479.6M | $573.1M |
| Total debt | $208.9M | $213.6M | $230.0M | $230.0M | $230.0M |
| Stockholders' equity | -$6.5M | $70.0M | $134.8M | $211.6M | $690.7M |
| Cash Flow Statement | |||||
| Cash from operations | $9.3M | -$8.8M | -$185,000 | -$53.9M | -$38.5M |
| Depreciation and amortization | $25.2M | $25.7M | $26.5M | $37.5M | $29.9M |
| Stock-based compensation | $28.1M | $40.4M | $41.0M | $44.7M | $50.3M |
| Capital expenditure | $480,000 | $1.6M | $667,000 | $1.2M | $3.1M |
| Free cash flow | $8.8M | -$10.4M | -$852,000 | -$55.1M | -$41.6M |
| Share repurchases | — | $0 | $0 | $40.0M | $0 |
| Impairments | $49.1M | $117.8M | $70.5M | $396.2M | — |
Shares outstanding 57.6M · Free float 76.3%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.